FDA Inspection 1014525 — Charles Lambert, M.D.
The FDA completed an inspection of Charles Lambert, M.D. on June 5, 2017 in Tampa, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- June 5, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Tampa, FL (United States)
Additional Details
Clinical Investigator (CI)